Shanghai Jiahui International Hospital recently announced the appointment of Dr. Jun Li as the Chief of Surgery, Chief of General Surgery and Chief of Surgical Oncology. In these roles, he will lead a team of outstanding doctors to provide comprehensive and high-quality surgical diagnostic and treatment services to patients.
Jun Li’s Journey in Medicine
Dr. Li graduated from the former Shanghai Medical University, now Fudan University, with a clinical Bachelor's Degree and earned a Master's Degree in Tumor Surgery from Fudan University Shanghai Cancer Center. In 1997, he moved to Germany to conduct scientific research. In 2002, he received his MD from the University of Essen in Germany and began his clinical practice.
After completing his residency at the University of Essen and receiving his license to practice medicine in 2007, he went on to specialize in surgical treatment of abdominal organs, especially hepatobiliary and pancreatic surgery and transplant surgery in four prestigious European University Hospitals — Essen University Hospital, Germany; Royal Free Hospital, University College London, United Kingdom; Tuebingen University Hospital, Germany and University Medical Center Hamburg-Eppendorf, Germany. In 2018, Hepato-Pancreatico-Biliary Surgery of University Medical Center Hamburg-Eppendorf, for which Li was responsible, was one of the five "Center of Excellence for Liver Surgery (DGAV)" in Germany.
Award Winning Experience
Dr. Li’s many innovative operations have been recognized and published in international journals. Some of them are:
2008 — “World First: White-test to Reduce Bile Leakage After Hepatectomy" published in Archive of Surgery
2008 — "World First: IMV Repair Hepatic Artery Injury" published in British Journal of Surgery
2016 — "World's First: Hybrid ALPPS" published in Annals of Surgery
2016 — "World's First Successful Case: Application of ALPPS in Right Hepatic Trilobectomy with Pancreaticoduodenectomy" published in Annals of Surgery
2017 —"World First Domino Split Liver Transplantation in ChilDr.en with MSUD” published in Pediatric Transplantation
2018 — "World's First: Pediatric Double Kidney Back Camel Transplantation" published in Pediatric Transplantation
Dr. Li is one of the few surgical experts who holds both European Board of Surgery certification in hepatobiliary and pancreatic surgery, and liver, pancreas and kidney transplant surgery. In addition, he is also a member of the German Surgery Association.
Born into a Family of Three Generations of Doctors
Dr. Li's uncle was the founder of Chinese cardiology, who introduced the first electrocardiogram machine in China and published China's first monograph on "Practical Cardiology."
Dr. Li's mother is a lifelong honorary professor in a prestigious hospital in Shanghai and has long been engaged in clinical research in gastroenterology and liver diseases. She also actively promotes the development of clinical epidemiology and introduced the concept of "evidence-based medicine" in China.
Two of Dr. Li’s cousins are professors and directors in the top three hospitals in Shanghai, including one who is also a leading talent of the Ministry of Science and Technology and a winner of the National Science Fund for Outstanding Youth.
Dr. Li himself has extensive surgical skills and specializes in liver tumors, bile duct tumors, pancreatic and other abdominal tumor surgery, liver and pancreatic malignancies, cysts, gallstones, peritoneal and retroperitoneal tumors, gastrointestinal tumors and lymph nodes. He has rich clinical experience in biopsy and dissection, pancreatic and other abdominal tumor surgery, and he especially excels in liver cancer metastasis to help patients recover from advanced cancer.
At the same time, Dr. Li is also proficient in various diagnostic and treatment techniques such as laparoscopic surgery and is good at reconstruction of blood vessels, bile ducts and intestines and a variety of innovative minimally invasive surgical procedures.
First Hand Experience as a Cancer Caregiver
While he was working in Germany, Dr. Li's then 58-year-old mother was diagnosed with a malignant lump during a physical examination. He helped plan the surgery and chemotherapy and returned to China to care for his mother during chemotherapy. During his mother's remission, they vacationed in Europe, with Li continuing to care for her recovery and providing both physical and emotional support. After more than a year of physical therapy and emotional healing, Dr. Li's mother was completely cured of cancer.
The survival experience of his mother's cancer made Dr. Li think deeply about the treatment experience of cancer patients. He understands the complexity of cancer treatment and knows that it is not only physiological but also psychological, which is in line with Jiahui's mission and values. In his new roles, Dr. Li will drive the comprehensive range of services and treatments for cancer patients and lead the fight against cancer.
Jiahui Strategic Collaboration with the Oldest and Largest Teaching Hospital of Harvard Medical School
As a strategic partner of Massachusetts General Hospital, which includes Cancer Center in China, Jiahui International Cancer Center (JICC) implements the International Tumor Board system. It provides international, multidisciplinary care that integrates individualized medicine, precision medicine and rapid recovery approaches to tumor diagnosis and treatment so that cancer patients receive appropriate scientific treatment plans that improve quality of life. To provide multidisciplinary care, the working team consists of medical professionals from various departments such as oncology, radiation therapy, surgery, pathology, imaging and nutrition.
As the Chief of Surgical Oncology, Dr. Li will continue to conduct in-depth research in the surgical fields of liver tumors, biliary tumors, pancreas and other abdominal tumors. He will promote academic exchange through his membership in several international associations for surgery, transplantation, hepatobiliary and pancreatic diseases.
In addition, Dr. Li will guide doctors at Jiahui to pursue new specialties such as neurosurgery, thoracic surgery and urology based on existing general surgery, orthopedics, breast surgery and pediatric surgery, and introduce multidisciplinary diagnosis and treatment plans. JICC will work closely with Gastroenterology to fully leverage their expertise and provide optimized clinical solutions and comprehensive one-stop diagnostic and treatment services for cancer patients.